European Medicines Agency - Regulatory - Regulation of medicines

6 -Public Involvement



    Description

Name

 

Newcastle-CCLG - Newcastle Children's Cancer and Leukaemia Pharmacology Studies Group

Involvement of patients, parents or their organisations in the protocol design Yes We seek advice from the patient advocacy group PORT in relation to the information sheets provided as part of our clinical trials. A member of ICCCPO (International Confederation of Childhood Cancer Parent Organisations) also sits on the Data Safety and Ethics Monitoring Committee which independently reviews our studies.
Involvement of patients, parents or their organisations in creating the protocol info package Yes See above.
Involvement of patients, parents or their organisations in prioritisation of needs for Clinical Trials No